Skip to content

    ANI PHARMACEUTICALS (ANIP) stock price & financials

    View ANIP earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance20.7% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $148.33M
    $190.57M
    $197.12M
    $211.37M
    $227.81M
    +53.6%
    $247.06M
    +29.6%
    $237.46M
    +20.5%
    $266.04M
    +25.9%
    Strengthening
    Operating Profit
    -$20.52M
    -$4.38M
    $26.19M
    $13.89M
    $36.24M
    $34.77M
    $38.89M
    +48.5%
    $40.46M
    +191.2%
    Strengthening
    Net Profit
    -$24.17M
    -$10.28M
    $15.68M
    $8.55M
    $26.62M
    $27.49M
    $29.49M
    +88.1%
    $24.71M
    +189.1%
    Strengthening
    EPS
    $-1.27
    $0.70
    $0.37
    $1.19
    $1.31
    +87.1%
    $1.09
    +194.6%
    Strengthening
    Other Income
    Interest
    Depreciation
    Profit before Tax
    -$31.50M
    -$13.76M
    $19.99M
    $10.53M
    $33.80M
    $31.48M
    $40.22M
    +101.2%
    $37.10M
    +252.5%
    Strengthening
    MarginsOPM
    -13.8%
    -2.3%
    13.3%
    6.6%
    15.9%
    14.1%
    16.4%
    +23.3%
    15.2%
    +131.5%
    Strengthening
    Tax
    23.3%
    25.3%
    21.5%
    18.8%
    21.3%
    -8.7%
    12.7%
    -50.0%
    26.7%
    +23.9%
    33.4%
    +77.9%
    Strengthening
    ReturnsROIC
    -77.7%
    -33.0%
    50.4%
    27.5%
    85.6%
    88.4%
    94.8%
    +88.1%
    79.4%
    +189.1%
    Strengthening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$43.01M$62.33M$7.86M$100.30M$48.23M$221.12M$144.89M$285.58M$360.21M
    Short-Term Investments
    Total Current Assets$152.88M$187.69M$170.32M$321.77M$344.26M$519.82M$528.46M$753.12M$825.43M
    Net PP&E$38.09M$40.55M$41.27M$52.67M$43.25M$44.59M$56.86M$62.48M$73.22M
    Goodwill$3.58M$3.58M$3.58M$27.89M$28.22M$28.22M$59.99M$62.48M$62.48M
    Intangibles$201.60M$180.39M$188.51M$294.12M$251.63M$209.01M$541.83M$479.53M$449.86M
    Total Assets$430.60M$456.79M$461.19M$771.60M$760.09M$904.42M$1.28B$1.44B$1.49B
    LiabilitiesTotal Current Liabilities$165.55M$61.68M$78.56M$87.54M$99.44M$145.48M$194.45M$278.11M$283.65M
    Short-Term Debt$3.26M$9.94M$13.24M$850.0K$850.0K$850.0K$9.17M$17.27M$21.33M
    Long-Term Debt$67.30M$175.81M$172.44M$286.52M$285.67M$284.82M$309.11M$291.84M$280.15M
    Long-Term Leases$292.0K$172.0K$995.0K$1.38M$4.11M$4.39M$9.17M
    Total Liabilities$233.34M$244.00M$265.49M$412.86M$421.55M$446.82M$855.94M$899.65M$896.90M
    EquityCommon Stock & APIC$1.0K$1.0K$1.0K$1.0K$1.0K$2.0K$2.0K$3.0K$3.0K
    Retained Earnings$11.49M$17.58M-$4.97M-$47.77M-$97.29M-$80.13M-$100.28M-$23.10M$31.10M
    Total Equity$197.26M$212.79M$195.70M$333.89M$313.69M$432.75M$403.68M$540.72M$597.21M
    HighlightsNet Cash / (Debt)-$27.54M-$123.42M-$177.82M-$187.07M-$238.29M-$64.55M-$173.39M-$23.52M$58.73M

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating$67.07M$45.63M$15.27M$3.32M-$31.20M$118.96M$64.02M$185.22M$189.47M
    Cash from Investing-$27.38M-$27.55M-$68.32M-$105.48M-$15.74M-$18.51M-$404.72M-$34.32M-$21.94M
    Cash from Financing-$27.82M$1.25M-$1.44M$194.59M-$5.13M$67.44M$264.94M-$9.94M-$24.55M
    SummaryCapital Expenditure-$5.74M-$6.63M-$6.13M-$2.56M-$8.88M-$8.87M-$16.24M-$13.84M-$16.48M
    Free Cash Flow$61.33M$39.00M$9.13M$765.0K-$40.08M$110.09M$47.78M$171.39M$172.99M
    FCF Margin30.4%18.9%4.4%0.4%-12.7%22.6%7.8%19.4%17.7%

    Ratios